Immune Thrombocytopenia

• CLINICAL_TRIALS trial_result · 2010-02-23
  Clinical Trial Update: RAISE: Randomized Placebo-Controlled Idiopathic Thrombocytopenic Purpura (ITP) Study With Eltrombopag [Phase 3]

  Phase 3 randomized, placebo-controlled trial of eltrombopag in idiopathic immune thrombocytopenia completed. Results were posted in 2010.

• CLINICAL_TRIALS trial_result · 2009-12-31
  Clinical Trial Update: Clinical Evaluation of SB-497115-GR in Chronic Idiopathic Thrombocytopenic Purpura (ITP) [Phase 3]

  This is a Phase 3 clinical evaluation of SB-497115-GR for chronic immune thrombocytopenia. The trial has completed and its results were post…

• CLINICAL_TRIALS trial_result · 2009-11-17
  Clinical Trial Update: Safety and Efficacy of Romiplostim in Immune Thrombocytopenia (ITP) in the " Real-life " : Result of the French Experience in 72 Adults

  This clinical trial update evaluates the real-world safety and efficacy of romiplostim in adults with immune thrombocytopenia in France. Dat…

• CLINICAL_TRIALS trial_result · 2009-08-11
  Clinical Trial Update: Repeated Exposure to Eltrombopag in Adults With Idiopathic Thrombocytopenic Purpura (REPEAT) [Phase 2]

  Phase 2 REPEAT trial evaluating repeated exposure to eltrombopag in adults with immune thrombocytopenia has completed and results were poste…

• CLINICAL_TRIALS trial_result · 2008-09-09
  Clinical Trial Update: Phase II Study of Rituximab in Patients With Immune Thrombocytopenic Purpura [Phase 2]

  A Phase II trial of rituximab for immune thrombocytopenia has completed.

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• CLINICAL_TRIALS trial_result · 2008-03-04
  Clinical Trial Update: Daclizumab to Treat Chronic Immune Thrombocytopenia [Phase 2]

  Phase 2 clinical trial of daclizumab for chronic immune thrombocytopenia has completed.

• CLINICAL_TRIALS trial_result · 2008-03-04
  Clinical Trial Update: An Epidemiological Study of Subjects With Immune Thrombocytopenic Purpura to Evaluate the Relationship Between Platelet Counts, Endogenous Thrombopoietin Levels, Endogenous Anti-Thrombopoietin Antibodies, and Selected Autoimmune Markers

  A completed NHLBI observational trial in immune thrombocytopenia examined how platelet counts relate to endogenous thrombopoietin levels, en…